Introduction
The frequency of invasive fungal infections has increased significantly over the past 2 decades (1, 2) . This increase in infection is associated with excessive morbidity and mortality (3) and is directly related to the increasing numbers of patients who are at risk for the development of serious fungal infections, including patients undergoing blood and marrow transplantation, solid-organ transplantation, and major surgery (especially gastrointestinal surgery); patients with AIDS, neoplastic disease, and advanced age; patients receiving immunosuppressive therapy; and premature infants (4, 5) . Members of the genus Candida are natural inhabitants of the skin, gastrointestinal, genital, and upper respiratory tracts of humans and animals (6) . Candida species were reported to be the fourth most common cause of bloodstream infections with high mortality rates (7) . They were isolated as causative agents in 10%-15% of all nosocomial infections, 70%-80% of all nosocomial fungal infections, and 8%-10% of nosocomial bloodstream infections (8) . C. albicans, C. glabrata, C. tropicalis, and C. parapsilosis were the most frequently encountered causative agents in systemic candidiasis (9, 10) .
C. zeylanoides is relatively rare in humans and animals, but it is included in the Atlas of Clinical Fungi (11) and has been reported on skin, nails, and blood as an opportunistic yeast pathogen and also in a report of endocarditis in an HIV-positive patient (12) (13) (14) (15) . Hazen (14) described C. zeylanoides as a new and emerging pathogen and observed that this yeast could be isolated from blood cultures repeatedly, indicating a constant shedding into the bloodstream. In previous studies, this fungus has been reported from the skin of a bottlenose dolphin in Japan and the genital tract of Iranian female camels (16, 17) . The purpose of this study was to investigate the pathogenicity of different doses of C. zeylanoides in BALB/c mice. Since this study has proven this fungus can invade tissues in this exact condition, it seems it will be categorized as an emerging opportunistic fungus in the future.
Merck Co., Darmstadt, Germany) at 35 °C for 24 h. For re-identification of the yeast CHROM agar, β-glucosidase test, urease test, sugar fermentation, and assimilation tests by RAPID yeast plus system (Remel Inc., USA) were used as major taxonomic criteria. Yeast cells from at least 5 colonies 1 mm in diameter were suspended in 5 mL of sterile 0.85% saline, and cell concentrations were adjusted using a hemocytometer. The viable count was confirmed by serially diluting the yeast suspension 10-fold and plating each inoculum onto Sabouraud dextrose agar plates. 6 cells, and a control group in which the mice were inoculated intravenously with sterile normal saline. Clinical signs and survival time were evaluated for 4 weeks after yeast inoculation.
Experimental systemic candidiasis

Tissue culture and pathology
All the euthanized mice and those that died spontaneously were subjected to detailed necropsy examinations under aseptic conditions.
For tissue culture, representative tissue samples from the brain, lungs, kidneys, liver, and spleen of the infected animals were removed, placed in glass vials containing 10 mL of sterile saline, and subsequently homogenized. One hundred milligrams of the homogenates was made in sterile normal saline and cultured on Sabouraud dextrose agar containing antibacterial antibiotics (20 IU penicillin and 40 µg/mL streptomycin). The plates were incubated at 35 °C for 14 days, and fungal colonies were counted and expressed as colony forming units (CFUs) per gram of tissue.
For histological examination, tissue samples were fixed in 10% neutral buffered formalin, embedded in paraffin wax, sectioned at 5-7 µm, and stained with hematoxylin and eosin (HE). Selected sections were stained with periodic acid-Schiff (PAS) as well.
Results
Clinically early deaths occurred 2-4 days postinoculation (PI) in group 1, and neurological signs such as circling, ataxia, severe movements of the head, tilting of the head and neck towards one side, and somnolence in groups 2, 3, and 4 were monitored. These signs were observed more severely in group 3. The mortalities occurred within 7-12 days PI in group 2 and 15-25 days PI in group 3. Although no animals died in groups 4 and 5, in group 4 animals had mild clinical signs. The animals in groups 4, 5, and the control group were euthanized 30 days PI ( Table 1) .
The results of tissue cultures are given in Table 2 as log CFU/g. The highest burden of C. zeylanoides was found in the kidneys, followed by the brain, lungs, liver, and spleen in all treatment groups (Figure 1 ).
In the histological examinations, masses of round to oval budding yeast cells (blastospores) measuring 3-5 µm in diameter along with a few pseudohyphae in different tissues were observed. Focal necrosis with glial cell aggregation, perivascular cuffing, hemorrhage zones around vessels, focal gliosis, and vascular edema accompanying the yeast cells inside the macrophages were determined in the brain (Figure 2 ). Mostly, multifocal necrosis, hemorrhage, and mononuclear interstitial infiltrations were detected in the kidneys (Figure 3) . Infiltration of polymorphonuclear cells (PMNs) and hyperemia were predominant in the lungs. Numerous aggregations of yeast cells were observed in 
*No clinical signs were observed in control group. the brain (Figure 4 ), but single or few yeast cells with buds were determined in the other studied tissues.
Discussion
Candida infections are a growing problem among immunocompromised subjects (1) . Although most episodes of candidiasis are still caused by C. albicans, opportunistic infections due to other Candida species have been reported with increasing frequency (18) . There is little information regarding C. zeylanoides pathogenicity (5,9). The involvement of this yeast in fungemia, arthritis, endocarditis, and skin infections in humans was documented (13, 14) . In a study by Shokri et al. (16) , C. zeylanoides was isolated as the predominant (20.3%) yeast flora in the genital tract of Iranian female camels. In the present study, a systemic candidiasis was induced in BALB/c mice following intravenous inoculation of C. zeylanoides and observations were recorded until death. Clinical signs observed in the infected mice were initially characterized by circling, ataxia, and neurological signs along with restlessness in the later stages. These findings can be attributed to severe stress due to systemic fungal infections, which are compatible with previous reports with experimental candidiasis in other animal models (19) . The results of this study showed that an injection of 1 × 10 8 yeast cells leads to early death in mice, with the average survival time of 2 days. In a previous study, by Riazipour et al. (20) , the mean survival time in BALB/c mice infected with C. albicans (1 × 10 6 cells intravenously) was determined as approximately 12.4 days. In our study animals in group 5 that were inoculated with the same dose as C. albicans did not reveal any clinical signs during the 30 days. Interestingly, for the mice in group 2, which were injected with 2 × 10 7 yeast cells, the survival time was up to 9.5 days. It seems that the survival time in the abovementioned dose is close to injection with 1 × 10 6 cells of C. albicans. In comparison to C. albicans, C. zeylanoides is less virulent and indicates a higher survival time in infected animals. In a previous study, the esterase activities of C. albicans and C. zeylanoides isolates were evaluated. It was revealed that enzymatic activity of C. zeylanoides was weak, whereas C. albicans showed strong enzymatic activity (21) . It seems that esterase and other enzymes have important roles in Candida invasion.
In this study, the presence of fungal elements in different tissues, especially in the kidneys and brain, and perivascular invasion were the most predominant microscopic characteristics of systemic candidiasis. The histological findings were initially characterized by congestion and hemorrhages in different tissues along with focal areas of necrosis. These were followed by the development of multiple microabscesses in the kidneys, brain, lungs, liver, and spleen, in order of severity. Mean infection rate was significantly higher in the kidneys (6 × 10 4 CFU/g) than it was in the other organs. Brown et al. (22) reported that Candida organisms multiplied to a greater extent in the kidneys than in the liver, spleen, and lungs of rats and mice. As mentioned, discrepancy in Candida distribution is dependent on the animal species challenged, the growth conditions used for the challenge inoculum, differences between fungal strains, and the route of Candida species inoculation.
Many studies have reported kidney fungal burden as the primary endpoint when analyzing the virulence and/or the susceptibility of Candida species in mice with systemic candidiasis (23, 24) . Importantly, there are significant differences among the endothelial cells that line the vasculature of the different organs, as well as the immunologic milieu of these organs (25) . These differences provide a compelling rationale to investigate the capacity of Candida species to traffic to and persist in organs other than the kidney. The brain is a particularly important target organ in subjects with hematogenously disseminated candidiasis (26) . To invade the brain parenchyma, blood-borne Candida cells must adhere to and traverse the endothelial cell lining of the blood vessels within the central nervous system. Brain endothelial cells are significantly different from those lining systemic blood vessels. For example, they have tight junctions that are not present in the endothelial cells in other vascular beds (27) .
In conclusion, an increase in inoculum size was associated with an increase in the mortality rate of the infected mice. The highest counts of C. zeylanoides were recovered from the kidneys, followed by the brain, lungs, liver, and spleen. We suggest that use of survivalstandardized inocula provides a novel approach for future investigations to differentiate early-and late-stage host and pathogen factors involved in the infectious disease process with this fungus. Since the various components of the cell wall and cytoplasm of Candida species are important in the pathogenicity, this study should be continued to obtain the exact virulence factors in C. zeylanoides.
